Flerie AB (publ) (STO:FLERIE)

Market Cap	1.17B -63.0%
Revenue (ttm)	2.60M +4.0%
Net Income	-975.30M
EPS	-10.32
Shares Out	86.70M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,105
Open	13.75
Previous Close	13.90
Day's Range	13.45 - 13.75
52-Week Range	13.00 - 35.74
Beta	-0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 15, 2026

About Flerie AB

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: FLERIE

Financial Performance

In 2025, Flerie AB's revenue was 2.50 million, a decrease of -3.85% compared to the previous year's 2.60 million. Losses were -756.90 million, 232.0% more than in 2024.

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 2, 2026

Data Sources Report a data error